Treatment of degenerations and light-induced damage to the retina
US9872858B2 · kind B2 · utility
2Cited by
0References
13Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jan 28, 2015 |
| Grant date | Jan 23, 2018 |
| Priority date | — |
| Expiry date | Jan 28, 2035 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P27/02
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates to a compound of the following formula (I):or a pharmaceutically acceptable salt thereof, to be used in the prevention or treatment of light-induced damage and/or a degeneration of the retina in a patient.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.